Nitric oxide and zinc-mediated protein assemblies involved in Mu opioid receptor signaling

Molecular Neurobiology

Volumn 48, Issue 3, 2013, Pages 769-782

  Rodríguez Muñoz, María ^a   Garzón, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Glutamate NMDA receptor; Mu opioid receptor; Nitric oxide; Opioid signaling; Redox signaling; Zinc metabolism

Indexed keywords

CYSTEINE; DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; LYSOPHOSPHOLIPASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; NUCLEOTIDE BINDING PROTEIN; NUCLEOTIDE BINDING PROTEIN 1; PROTEIN KINASE C; PROTEIN KINASE C GAMMA; RAF PROTEIN; RGSZ2 PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC ION;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL SURVIVAL; DIFFERENTIATION; DRUG POTENCY; ENZYME ACTIVATION; EX VIVO STUDY; HUMAN; IN VITRO STUDY; MOLECULAR INTERACTION; MORPHINE TOLERANCE; NERVOUS SYSTEM; NONHUMAN; PDZ DOMAIN; PLASTICITY; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; ZINC METABOLISM;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; NITRIC OXIDE; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; ZINC;

EID: 84885865613     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8465-z     Document Type: Review

References (104)

1. Huidobro F, Huidobro-Toro JP, Way EL (1976) Studies on tolerance development to single doses of morphine in mice. J Pharmacol Exp Ther 198:318-329
2. Kornetsky C, Bain G (1968) Morphine: single-dose tolerance. Science 162:101-102
3. 2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharmacol Exp Ther 277:484-490
4. Huidobro-Toro JP, Way EL (1978) Single-dose tolerance to antinociception, and physical dependence on beta-endorphin in mice. Eur J Pharmacol 52:179-189
5. Fairbanks CA, Wilcox GL (1997) Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 282:1408-1417
6. Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Garzón J (2007) Morphine induces endocytosis of neuronal m-opioid receptors through the sustained transfer of Ga subunits to RGSZ2 proteins. Mol Pain 3:19
7. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Berrocoso E, Garzón J (2012) The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology 37:338-349
8. Marie N, Aguila B, Allouche S (2006) Tracking the opioid receptors on the way of desensitization. Cell Signal 18:1815-1833
9. Wang ZJ, Wang LX (2006) Phosphorylation: a molecular switch in opioid tolerance. Life Sci 79:1681-1691
10. He L, Fong J, von Zastrow M, Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108:271-282
11. Finn AK, Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829-839
12. Tsao P, von Zastrow M (2000) Downregulation of G protein-coupled receptors. Curr Opin Neurobiol 10:365-369
13. Rodríguez-Muñoz M, de la Torre-Madrid E, Gaitán G, Sánchez-Blázquez P, Garzón J (2007) RGS14 prevents morphine from internalizing mu-opioid receptors in periaqueductal gray neurons. Cell Signal 19:2558-2571
14. oa subunits restore the efficacy of opioids, clonidine and neurotensin giving rise to antinociception in G-protein knock-down mice. Neuropharmacology 38:1861-1873
15. i2a subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice. Neuropharmacology 40:560-569
16. Maher CE, Martin TJ, Childers SR (2005) Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration. Life Sci 77:1140-1154
17. Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ (2000) Chronic heroin self-administration desensitizes m opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20:4555-4562
18. 35S]GTPgS autoradiography in rat brain. J Neurosci 16:2684-2692
19. Garzón J, Rodríguez-Díaz M, López-Fando A, Sánchez-Blázquez P (2001) RGS9 proteins facilitate acute tolerance to mu-opioid effects. Eur J Neurosci 13:801-811
20. Garzón J, Rodríguez-Díaz M, López-Fando A, García-España A, Sánchez-Blázquez P (2002) Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain. Neuropharmacology 42:813-828
21. Garzón J, Rodriguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P (2005) Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychopharmacology (Berl) 180:1-11
22. Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005) Activation of m-opioid receptors transfers control of Ga subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization. J Biol Chem 280:8951-8960
23. Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005) The RGSZ2 protein exists in a complex with m-opioid receptors and regulates the desensitizing capacity of Gz proteins. Neuropsychopharmacology 30:1632-1648
24. Ibi M, Matsuno K, Matsumoto M, Sasaki M, Nakagawa T, Katsuyama M et al (2011) Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance. J Neurosci 31:18094-18103
25. Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ et al (2011) A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J Neurosci 31:5617-5624
26. Sánchez-Blázquez P, Rodríguez-Muñoz M, Montero C, Garzón J (2005) RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Gaz subunits. Neuropharmacology 48:134-150
27. Garzón J, Rodriguez-Muñoz M, Sánchez-Blázquez P (2008) Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr Drug Abuse Rev 1:222-238
28. Garzón J, Rodríguez-Muñoz M, Sánchez-Blazquez P (2012) Direct association of mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. Curr Drug Abuse Rev 5:199-226
29. Sánchez-Blázquez P, Rodríguez-Muñoz M, Bailón C, Garzón J (2012) GPCRs promote the release of zinc ions mediated by nNOS/NO and the redox transducer RGSZ2 protein. Antioxid Redox Signal 17:1163-1177
30. Lima CD, Klein MG, Hendrickson WA (1997) Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science 278:286-290
31. Brenner C (2002) Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 41:9003-9014
32. Pearson JD, DeWald DB, Mathews WR, Mozier NM, Zurcher-Neely HA, Heinrikson RL et al (1990) Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem 265:4583-4591
33. McDonald JR, Groschel-Stewart U, Walsh MP (1987) Properties and distribution of the protein inhibitor (Mr 17,000) of protein kinase C. Biochem J 242:695-705
34. Martin J, St-Pierre MV, Dufour JF (2011) Hit proteins, mitochondria and cancer. Biochim Biophys Acta 1807:626-632
35. Huber O, Weiske J (2008) Beta-catenin takes a HIT1. Cell Cycle 7:1326-1331
36. Guang W, Wang H, Su T, Weinstein IB, Wang JB (2004) Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol Pharmacol 66:1285-1292
37. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Bailón C, Martín-Aznar B, Garzón J (2011) The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Cell Mol Life Sci 68:2933-2949
38. Ajit SK, Ramineni S, Edris W, Hunt RA, Hum WT, Hepler JR et al (2007) RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling. Cell Signal 19:723-730
39. Rodríguez-Muñoz M, Torre-Madrid E, Sánchez- Blázquez P, Wang JB, Garzón J (2008) NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of mu-opioid receptors. Cell Signal 20:1855-1864
40. Lima CD, Klein MG, Weinstein IB, Hendrickson WA (1996) Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci U S A 93:5357-5362
41. Bardaweel S, Pace J, Chou TF, Cody V, Wagner CR (2010) Probing the impact of the echinT C-terminal domain on structure and catalysis. J Mol Biol 404:627-638
42. Rodríguez-Muñoz M, Torre-Madrid E, Sánchez- Blázquez P, Garzón J (2011) NO-released zinc supports the simultaneous binding of Raf-1 and PKCgamma cysteine-rich domains to HINT1 protein at the mu-opioid receptor. Antioxid Redox Signal 14:2413-2425
43. Korichneva I, Hoyos B, Chua R, Levi E, Hammerling U (2002) Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem 277:44327-44331
44. Korichneva I (2006) Zinc dynamics in the myocardial redox signaling network. Antioxid Redox Signal 8:1707-1721
45. Hunt TW, Fields TA, Casey PJ, Peralta EG (1996) RGS10 is a selective activator of G alpha i GTPase activity. Nature 383:175-177
46. Berman DM, Kozasa T, Gilman AG (1996) The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem 271:27209-27212
47. Mao H, Zhao Q, Daigle M, Ghahremani MH, Chidiac P, Albert PR (2004) RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling. J Biol Chem 279:26314-26322
48. Garzón J, Rodríguez-Muñoz M, Vicente-Sánchez A, García-López MA, Martínez-Murillo R, Fischer T et al (2011) SUMO-SIM interactions regulate the activity of RGSZ2 proteins. PLoS One 6:e28557
49. Garzón J, Rodríguez-Muñoz M, Vicente-Sánchez A, Bailón C, Martínez-Murillo R, Sánchez-Blázquez P (2011) RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the N-methyl-d-aspartate receptor-calmodulin-dependent protein kinase II pathway. Antioxid Redox Signal 15:873-887
50. Rodríguez-Muñoz M, Bermúdez D, Sánchez- Blázquez P, Garzón J (2007) Sumoylated RGS-Rz proteins act as scaffolds for Mu-opioid receptors and G-protein complexes in mouse brain. Neuropsychopharmacology 32:842-850
51. Wang J, Tu Y, Woodson J, Song X, Ross EM (1997) A GTPase-activating protein for the G protein Galphaz. Identification, purification, and mechanism of action. J Biol Chem 272:5732-5740
52. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS (2007) Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 293:R821-R828
53. Rothe F, Langnaese K, Wolf G (2005) New aspects of the location of neuronal nitric oxide synthase in the skeletal muscle: a light and electron microscopic study. Nitric Oxide 13:21-35
54. Schwarz PM, Kleinert H, Forstermann U (1999) Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta. Arterioscler Thromb Vasc Biol 19:2584-2590
55. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96:657-662
56. Stamler JS, Meissner G (2001) Physiology of nitric oxide in skeletal muscle. Physiol Rev 81:209-237
57. Lau KS, Grange RW, Isotani E, Sarelius IH, Kamm KE, Huang PL et al (2000) nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics 2:21-27
58. Santizo R, Baughman VL, Pelligrino DA (2000) Relative contributions from neuronal and endothelial nitric oxide synthases to regional cerebral blood flow changes during forebrain ischemia in rats. Neuroreport 11:1549-1553
59. Boissel JP, Schwarz PM, Forstermann U (1998) Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide 2:337-349
60. Reif A, Frohlich LG, Kotsonis P, Frey A, Bommel HM, Wink DA et al (1999) Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem 274:24921-24929
61. Sagami I, Daff S, Shimizu T (2001) Intra-subunit and inter-subunit electron transfer in neuronal nitric-oxide synthase: effect of calmodulin on heterodimer catalysis. J Biol Chem 276:30036-30042
62. Noguchi T, Sagami I, Daff S, Shimizu T (2001) Important role of tetrahydrobiopterin in no complex formation and interdomain electron transfer in neuronal nitric-oxide synthase. Biochem Biophys Res Commun 282:1092-1097
63. Hemmens B, Goessler W, Schmidt K, Mayer B (2000) Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. J Biol Chem 275:35786-35791
64. Roman LJ, Masters BS (2006) Electron transfer by neuronal nitric-oxide synthase is regulated by concerted interaction of calmodulin and two intrinsic regulatory elements. J Biol Chem 281:23111-23118
65. Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J (2010) Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5:e11278
66. Chen L, Huang LY (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a m opioid. Neuron 7:319-326
67. Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD et al (1999) G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 2:331-338
68. Ali DW, Salter MW (2001) NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 11:336-342
69. Salter MW, Kalia LV (2004) Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 5:317-328
70. Ma YC, Huang J, Ali S, Lowry W, Huang XY (2000) Src tyrosine kinase is a novel direct effector of G proteins. Cell 102:635-646
71. Thornton C, Yaka R, Dinh S, Ron D (2003) H-Ras modulates N-methyl-d-aspartate receptor function via inhibition of Src tyrosine kinase activity. J Biol Chem 278:23823-23829
72. Sánchez-Blázquez P, Rodríguez-Muñoz M, de la Torre-Madrid E, Garzón J (2009) Brain-specific Gaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway. Cell Signal 21:1444-1454
73. 2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Trends Neurosci 22:12-16
74. Trujillo KA (2002) The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity. Neurotox Res 4:373-391
75. Glass MJ, Vanyo L, Quimson L, Pickel VM (2009) Ultrastructural relationship between N-methyl-d-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala. Neuroscience 163:857-867
76. Commons KG, van Bockstaele EJ, Pfaff DW (1999) Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J Comp Neurol 408:549-559
77. Narita M, Hashimoto K, Amano T, Narita M, Niikura K, Nakamura A et al (2008) Post-synaptic action of morphine on glutamatergic neuronal transmission related to the descending antinociceptive pathway in the rat thalamus. J Neurochem 104:469-478
78. Mori H, Mishina M (1995) Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237
79. Zukin RS, Bennett MV (1995) Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 18:306-313
80. Maret W, Vallee BL (1998) Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci U S A 95:3478-3482
81. Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79-118
82. Maret W (2009) Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. Biometals 22:149-157
83. Colvin RA, Holmes WR, Fontaine CP, Maret W (2010) Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2:306-317
84. Bitanihirwe BK, Cunningham MG (2009) Zinc: the brain's dark horse. Synapse 63:1029-1049
85. Maret W (2006) Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid Redox Signal 8:1419-1441
86. Shahani N, Sawa A (2011) Nitric oxide signaling and nitrosative stress in neurons: role for S-nitrosylation. Antioxid Redox Signal 14:1493-1504
87. Maret W (2000) The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 130:1455S-1458S
88. Ilbert M, Graf PC, Jakob U (2006) Zinc center as redox switch - new function for an old motif. Antioxid Redox Signal 8:835-846
89. Palumaa P (2009) Biological redox switches. Antioxid Redox Signal 11:981-983
90. Newton AC (2001) Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101:2353-2364
91. Zhao F, Ilbert M, Varadan R, Cremers CM, Hoyos B, Acin-Perez R et al (2011) Are zinc-finger domains of protein kinase C dynamic structures that unfold by lipid or redox activation? Antioxid Redox Signal 14:757-766
92. Knapp LT, Klann E (2000) Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem 275:24136-24145
93. Tsui J, Inagaki M, Schulman H (2005) Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation. J Biol Chem 280:9210-9216
94. 2+/Calmodulin. J Biol Chem 272:17038-17044
95. Rameau GA, Chiu LY, Ziff EB (2004) Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at serine 847 by the N-methyl-d-aspartate receptor. J Biol Chem 279:14307-14314
96. Kroncke KD, Klotz LO (2009) Zinc fingers as biologic redox switches? Antioxid Redox Signal 11:1015-1027
97. Kalia LV, Salter MW (2003) Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology 45:720-728
98. Kalia LV, Pitcher GM, Pelkey KA, Salter MW (2006) PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. EMBO J 25:4971-4982
99. Koch T, Kroslak T, Mayer P, Raulf E, Höllt V (1997) Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin- dependent protein kinase II in agonist-mediated desensitization. J Neurochem 69:1767-1770
100. Chen Y, Sommer C (2009) The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol 40:101-107
101. Polakiewicz RD, Schieferl SM, Dorner LF, Kansra V, Comb MJ (1998) A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J Biol Chem 273:12402-12406
102. Hoyos B, Imam A, Chua R, Swenson C, Tong GX, Levi E et al (2000) The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J Exp Med 192:835-845
103. Doyle T, Bryant L, Muscoli C, Cuzzocrea S, Esposito E, Chen Z et al (2010) Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci Lett 483:85-89
104. Bokoch GM, Diebold B, Kim JS, Gianni D (2009) Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal 11:2429-2441